FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

The research group of Prof. Sanjiv Luther at the Department of Immunobiology of the University of Lausanne has discovered ...

Patterns of fat metabolism in fibroblasts surrounding the tumor cells direct whether epithelial cancer cells become more ...

The research group of prof. Sanjiv Luther at the department of immunobiology of the University of Lausanne has discovered ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation ...

A team led by scientists from the Universities of Manchester and Liverpool have revealed why a group of cancers common in ...

The immune system is a complex response of various cells that detect and elicit mechanisms to eliminate disease. This ...

Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...

Researchers from Tomsk Polytechnic University, together with their colleagues from Mexico, studied and described molecular ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

The research group of Prof. Sanjiv Luther at the Department of Immunobiology, University of Lausanne, has discovered that a fibroblast subtype is essential for coordinating certain immune cells within ...